Seguir
Hagit Eldar-Finkelman
Hagit Eldar-Finkelman
Dirección de correo verificada de tauex.tau.ac.il - Página principal
Título
Citado por
Citado por
Año
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1
DJ Klionsky, AK Abdel-Aziz, S Abdelfatah, M Abdellatif, A Abdoli, S Abel, ...
autophagy 17 (1), 1-382, 2021
13704*2021
Glycogen synthase kinase 3: an emerging therapeutic target
H Eldar-Finkelman
Trends in molecular medicine 8 (3), 126-132, 2002
5192002
Phosphorylation of insulin receptor substrate 1 by glycogen synthase kinase 3 impairs insulin action
H Eldar-Finkelman, EG Krebs
Proceedings of the National Academy of Sciences 94 (18), 9660-9664, 1997
4251997
GSK-3 inhibitors: preclinical and clinical focus on CNS
H Eldar-Finkelman, A Martinez
Frontiers in molecular neuroscience 4, 32, 2011
3952011
Rapid antidepressive-like activity of specific glycogen synthase kinase-3 inhibitor and its effect on β-catenin in mouse hippocampus
O Kaidanovich-Beilin, A Milman, A Weizman, CG Pick, H Eldar-Finkelman
Biological psychiatry 55 (8), 781-784, 2004
3482004
Increased glycogen synthase kinase-3 activity in diabetes-and obesity-prone C57BL/6J mice.
H Eldar-Finkelman, SA Schreyer, MM Shinohara, RC LeBoeuf, EG Krebs
Diabetes 48 (8), 1662-1666, 1999
3431999
Leptin induces insulin-like signaling that antagonizes cAMP elevation by glucagon in hepatocytes
AZ Zhao, MM Shinohara, D Huang, M Shimizu, H Eldar-Finkelman, ...
Journal of Biological Chemistry 275 (15), 11348-11354, 2000
3152000
Inactivation of Glycogen Synthase Kinase-3 by Epidermal Growth Factor Is Mediated by Mitogen-activated Protein Kinase/p90 Ribosomal Protein S6 Kinase Signaling Pathway in NIH …
H Eldar-Finkelman, R Seger, JR Vandenheede, EG Krebs
Journal of Biological Chemistry 270 (3), 987-990, 1995
2821995
Overexpression of mitogen-activated protein kinase kinase (MAPKK) and its mutants in NIH 3T3 cells. Evidence that MAPKK involvement in cellular proliferation is regulated by …
R Seger, D Seger, AA Reszka, ES Munar, H Eldar-Finkelman, ...
Journal of Biological Chemistry 269 (41), 25699-25709, 1994
2571994
Inhibition of glycogen synthase kinase-3 ameliorates β-amyloid pathology and restores lysosomal acidification and mammalian target of rapamycin activity in the Alzheimer …
L Avrahami, D Farfara, M Shaham-Kol, R Vassar, D Frenkel, ...
Journal of Biological Chemistry 288 (2), 1295-1306, 2013
2422013
Increased glucose uptake promotes oxidative stress and PKC-δ activation in adipocytes of obese, insulin-resistant mice
I Talior, M Yarkoni, N Bashan, H Eldar-Finkelman
American Journal of Physiology-Endocrinology And Metabolism 285 (2), E295-E302, 2003
2332003
Serine 332 phosphorylation of insulin receptor substrate-1 by glycogen synthase kinase-3 attenuates insulin signaling
Z Liberman, H Eldar-Finkelman
Journal of Biological Chemistry 280 (6), 4422-4428, 2005
2252005
Inhibition of glycogen synthase kinase-3β by bivalent zinc ions: insight into the insulin-mimetic action of zinc
R Ilouz, O Kaidanovich, D Gurwitz, H Eldar-Finkelman
Biochemical and biophysical research communications 295 (1), 102-106, 2002
2152002
Insulin mimetic action of synthetic phosphorylated peptide inhibitors of glycogen synthase kinase-3
B Plotkin, O Kaidanovich, I Talior, H Eldar-Finkelman
Journal of Pharmacology and Experimental Therapeutics 305 (3), 974-980, 2003
1852003
Expression and characterization of glycogen synthase kinase-3 mutants and their effect on glycogen synthase activity in intact cells.
H Eldar-Finkelman, GM Argast, O Foord, EH Fischer, EG Krebs
Proceedings of the National Academy of Sciences 93 (19), 10228-10233, 1996
1721996
PKC-δ-dependent activation of oxidative stress in adipocytes of obese and insulin-resistant mice: role for NADPH oxidase
I Talior, T Tennenbaum, T Kuroki, H Eldar-Finkelman
American Journal of Physiology-Endocrinology And Metabolism 288 (2), E405-E411, 2005
1662005
The role of glycogen synthase kinase-3 in insulin resistance and type 2 diabetes
H Eldar-Finkelman, O Kaidanovich
Expert opinion on therapeutic targets 6 (5), 555-561, 2002
1502002
Role of glycogen synthase kinase-3β in early depressive behavior induced by mild traumatic brain injury
M Shapira, A Licht, A Milman, CG Pick, E Shohami, H Eldar-Finkelman
Molecular and Cellular Neuroscience 34 (4), 571-577, 2007
1392007
Long-term treatment with novel glycogen synthase kinase-3 inhibitor improves glucose homeostasis in ob/ob mice: molecular characterization in liver and muscle
O Kaidanovich-Beilin, H Eldar-Finkelman
Journal of Pharmacology and Experimental Therapeutics 316 (1), 17-24, 2006
1272006
Nuclear GSK-3β inhibits the canonical Wnt signalling pathway in a β-catenin phosphorylation-independent manner
M Caspi, A Zilberberg, H Eldar-Finkelman, R Rosin-Arbesfeld
Oncogene 27 (25), 3546-3555, 2008
1192008
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20